Oncology Institute Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.4% | 84.2% | 79.9% | 79.7% | 79.5% | 79.0% | 78.2% | 78.1% | 84.1% | 77.7% | 81.7% | 80.0% | 78.1% | 81.5% | 81.2% | 80.5% | 83.2% | 87.4% | 86.8% | 85.6% | 85.4% | 83.5% | 85.4% | 86.1% | 84.0% | 85.3% | 85.2% | |
| 22.6% | 15.8% | 20.1% | 20.3% | 20.5% | 21.0% | 21.8% | 21.9% | 15.9% | 22.3% | 18.3% | 20.0% | 21.9% | 18.5% | 18.8% | 19.5% | 16.8% | 12.6% | 13.2% | 14.4% | 14.6% | 16.5% | 14.6% | 13.9% | 16.0% | 14.7% | 14.8% | |
| – | 0.1% | 0.3% | 0.3% | 0.3% | 0.3% | 5.1% | 2.9% | 2.9% | 54.0% | 46.5% | 49.2% | 41.4% | 37.8% | 35.8% | 34.4% | 32.7% | 30.1% | 28.3% | 26.7% | 24.8% | 24.3% | 22.5% | 18.5% | 19.8% | 19.1% | 19.9% | |
| 25.7% | 21.8% | 19.8% | 21.8% | 30.7% | 24.6% | 24.1% | 26.0% | 94.0% | 55.8% | 48.3% | 50.9% | 57.0% | 61.6% | 37.5% | 36.5% | 34.6% | 31.6% | 29.8% | 28.2% | 26.5% | 26.0% | 24.0% | 19.8% | 20.9% | 19.1% | 20.8% | |
| -3.1% | -6.0% | 0.3% | -1.5% | -10.2% | -3.6% | -2.2% | -4.1% | -78.1% | -33.5% | -30.0% | -30.9% | -35.1% | -43.1% | -18.6% | -17.0% | -17.8% | -19.0% | -16.6% | -13.9% | -11.9% | -9.5% | -9.4% | -5.9% | -4.9% | -4.4% | -6.0% | |
| 0.0% | – | 0.2% | 0.2% | 0.5% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 2.3% | 3.4% | 3.5% | 3.3% | 3.3% | 2.3% | 2.1% | 2.1% | 2.2% | 1.2% | 5.3% | 1.6% | 1.4% | 1.3% | 1.3% | 1.4% | |
| -3.1% | -23.1% | 2.2% | -1.5% | -10.2% | -1.6% | 8.0% | -4.2% | -24.1% | 35.3% | -9.0% | -4.2% | -15.9% | -39.3% | -20.9% | -21.1% | -22.2% | -21.0% | -15.7% | -16.1% | -13.1% | -18.8% | -14.3% | -12.1% | -5.3% | -1.7% | -8.0% | |
| 2.2% | -0.7% | 0.1% | 0.0% | -0.4% | 0.4% | 1.6% | 1.5% | -4.7% | 0.3% | -0.1% | 0.0% | -0.5% | 0.1% | 0.1% | 0.2% | -0.4% | -0.3% | -2.8% | – | 3.6% | – | -0.1% | – | – | – | – | |
| -5.3% | -22.4% | 2.2% | -1.4% | -9.8% | -2.1% | 6.4% | -5.7% | -19.4% | 35.0% | -9.0% | -4.1% | -15.4% | -39.4% | -21.1% | -21.2% | -21.9% | -21.0% | -15.7% | -16.1% | -13.1% | -18.8% | -14.2% | -12.1% | -5.3% | -1.7% | -8.0% | |
| -1.1% | -4.2% | 4.1% | 0.2% | -8.4% | 0.2% | 9.8% | -2.4% | -22.3% | 37.2% | -7.1% | -0.1% | -20.5% | -19.3% | -16.9% | -14.9% | -16.1% | -17.3% | -12.0% | -12.3% | -10.3% | -11.7% | -11.2% | -9.4% | -2.8% | 0.7% | -5.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.